Mag-click dito kung ito ang iyong press release!

Losartan High Blood Pressure Medication Now Recalled

Sinulat ni editor

Ang Mint Pharmaceuticals Inc. ay binabawi ang lahat ng maraming mga de-resetang losartan tablet nito, sa 50 mg at 100 mg na lakas, matapos makita ng mga pagsusuri ang isang azido impurity (5-(4′-((5-(azidomethyl))-2-butyl-4-chloro) -1H imidazol-1-yl)methyl)-[1,1′-biphenyl]-2-yl)-1H tetrazole) na higit sa katanggap-tanggap na limitasyon. Ang pangmatagalang pagkakalantad sa karumihan sa mga antas na higit sa kung ano ang itinuturing na ligtas ay maaaring mapataas ang panganib ng kanser.

I-print Friendly, PDF at Email

Pakitingnan ang buong advisory para sa higit pang impormasyon, kabilang ang kung ano ang dapat gawin ng mga Canadian at ang gawain ng Health Canada upang matugunan ang isyu ng azido impurities na matatagpuan sa ilang partikular na gamot.

produktokompanyaMalaking ingayMaramiPag-expire
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMint Pharmaceuticals Inc.023896572005006959Abril 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMint Pharmaceuticals Inc.023896572005006960Abril 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMint Pharmaceuticals Inc.023896572005006961Abril 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMint Pharmaceuticals Inc.023896572005006962Abril 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMint Pharmaceuticals Inc.023896572005006963Abril 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMint Pharmaceuticals Inc.023896572005011154Hunyo 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMint Pharmaceuticals Inc.023896572005011156Hunyo 2023
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSMint Pharmaceuticals Inc.023896652005006807Abril 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSMint Pharmaceuticals Inc.023896652005006808Abril 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSMint Pharmaceuticals Inc.023896652005006809Abril 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSMint Pharmaceuticals Inc.023896652005006810Abril 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS Mint Pharmaceuticals Inc.023896652105002149Disyembre 2022
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896731805012687Oktubre 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896731805012688Oktubre 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896731805012689Oktubre 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896731805012792Oktubre 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896731905001010Disyembre 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS Mint Pharmaceuticals Inc.023896731905001011Disyembre 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896732005006947Abril 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896732005006949Abril 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896732005006950Abril 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896732005006951Abril 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS Mint Pharmaceuticals Inc.023896732005007297Abril 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896732005007298Abril 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896732005013776Agosto 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896732105002150Disyembre 2023
I-print Friendly, PDF at Email

Tungkol sa Author

editor

Pinuno ng editor si Linda Hohnholz.

Mag-iwan ng komento